1.
Schroecksnadel S, Suljkanovic J, Marth C, González-Martín A, Lorusso D. Case 1 – Long-term response to bevacizumab and paclitaxel as second-line therapy in metastatic vaginal carcinoma:  . CBN [Internet]. 2016 Mar. 15 [cited 2024 Nov. 23];4(1):36-40. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/203